121 related articles for article (PubMed ID: 6629296)
21. Clinical research into the hypolipemic and platelet antiaggregant activity of plafibride, Carried out in double-blind conditions and in comparison with clofibrate.
Palmieri B; Gasparini Casari M; DiBlasio P; Zirilli E
Arzneimittelforschung; 1981; 31(10a):1863-6. PubMed ID: 7032534
[TBL] [Abstract][Full Text] [Related]
22. [A trial of the use of the hypolipidemic preparation Lipanor (ciprofibrate) in patients with primary hyperlipidemia].
Kukharchuk VV; Rozhkova TA; Kotova LA; Tvorogova MG; Semenova OA
Ter Arkh; 1996; 68(6):58-61. PubMed ID: 8771689
[TBL] [Abstract][Full Text] [Related]
23. [Therapeutic experiences in the treatment of hyperlipoproteinaemia with etofylline clofibrate (author's transl)].
Vorberg G; Ziegler WJ
Arzneimittelforschung; 1980; 30(11b):2068-72. PubMed ID: 7194062
[TBL] [Abstract][Full Text] [Related]
24. Management of hypertension and dyslipidaemia in patients presenting with hyperuricaemia: case histories.
Milionis HJ; Elisaf MS
Curr Med Res Opin; 2000; 16(3):164-70. PubMed ID: 11191005
[TBL] [Abstract][Full Text] [Related]
25. [Therapy with fibrates and vitamin D metabolism].
Wilczek H; Sobra J; Ceska R; Justová V; Procházková R; Kvasilová M; Jůzová Z
Cas Lek Cesk; 1993 Oct; 132(20):630-2. PubMed ID: 8269466
[TBL] [Abstract][Full Text] [Related]
26. [Therapeutic effects of bezafibrate in hyperlipidemia].
Kunesová M; Honková M; Zeman M; Mares P; Skorepa J
Cas Lek Cesk; 1983 May; 122(20):628-31. PubMed ID: 6342789
[No Abstract] [Full Text] [Related]
27. Effect of sodium valproate monotherapy on serum uric acid concentrations in ambulatory epileptic children: a prospective long-term study.
Attilakos A; Voudris KA; Garoufi A; Mastroyianni S; Dimou S; Prassouli A; Katsarou E
Eur J Paediatr Neurol; 2006; 10(5-6):237-40. PubMed ID: 17035050
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the hypolipaemic activity of etofylline clofibrate, a new ester of etofylline and clofibric acid, and comparison with effects of known hypolipaemic agents.
Davies JE; Kellett DN
Arzneimittelforschung; 1980; 30(11b):2035-7. PubMed ID: 7194055
[TBL] [Abstract][Full Text] [Related]
29. [An alternative in the therapy of primary hyperlipemias: etofibrate in depot preparations].
Füsgen I; Summa JD
Med Klin; 1980 Nov; 75(23):823-5. PubMed ID: 7442597
[TBL] [Abstract][Full Text] [Related]
30. [Problems of long-term treatment of hyperlipoproteinemia with clofibrinic acid].
Hanefeld M; Schulze J; Fritz T; Kemmer C
Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:160 c. PubMed ID: 4200340
[No Abstract] [Full Text] [Related]
31. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
32. Effect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine.
Melenovsky V; Stulc T; Kozich V; Grauova B; Krijt J; Wichterle D; Haas T; Malik J; Hradec J; Ceska R
Am Heart J; 2003 Jul; 146(1):110. PubMed ID: 12851616
[TBL] [Abstract][Full Text] [Related]
33. [Clinical experimentation of clofibride. Apropos of 40 cases].
Warembourg H; Jaillard J
Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1292-6. PubMed ID: 4802928
[No Abstract] [Full Text] [Related]
34. Long-term treatment of hyperlipidemic patients with clofibrate.
Berkowitz D
JAMA; 1971 Nov; 218(7):1002-5. PubMed ID: 5000568
[No Abstract] [Full Text] [Related]
35. The metabolic spectrum of halofenate.
Ryan JR
Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):239-43. PubMed ID: 51838
[TBL] [Abstract][Full Text] [Related]
36. Pharmacologic therapy for the hyperlipidemic patient.
Hunninghake DB
Am J Med; 1983 May; 74(5A):19-22. PubMed ID: 6846378
[TBL] [Abstract][Full Text] [Related]
37. Halofenate: an effective hypolipemia- and hypouricemia-inducing drug.
Aronow WS; Vangrow JS; Nelson WH; Pagano J; Papageorge's NP; Khursheed M; Harding PR; Khemka M
Curr Ther Res Clin Exp; 1973 Dec; 15(12):902-6. PubMed ID: 4203573
[No Abstract] [Full Text] [Related]
38. Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children.
Tumgor G; Arikan C; Kilic M; Aydogdu S
Pediatr Transplant; 2006 Sep; 10(6):665-8. PubMed ID: 16911488
[TBL] [Abstract][Full Text] [Related]
39. [The effect of hypolipemic treatment on the pharmacokinetics of propranolol].
Sterna R
Ann Acad Med Stetin; 1997; 43():67-77. PubMed ID: 9471924
[TBL] [Abstract][Full Text] [Related]
40. [Effect of etofylline clofibrate on the composition of lipoproteins in hyperlipidaemia type IIb and IV (author's transl)].
Ditschuneit HH; Hutt V; Klör HU; Ditschuneit H
Arzneimittelforschung; 1980; 30(11b):2063-7. PubMed ID: 7194061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]